Health In Tech, Inc. (HIT)
| Market Cap | 24.91M -72.6% |
| Revenue (ttm) | 30.92M +0.7% |
| Net Income | -11.47M |
| EPS | -0.19 |
| Shares Out | 65.53M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 65,121 |
| Open | 0.3850 |
| Previous Close | 0.3816 |
| Day's Range | 0.3636 - 0.4099 |
| 52-Week Range | 0.3000 - 2.1000 |
| Beta | n/a |
| Analysts | Buy |
| Price Target | 2.37 (+522.73%) |
| Earnings Date | Nov 12, 2026 |
About HIT
Health In Tech, Inc. operates as an insurance technology platform company in the United States. The company offers reference-based pricing, group insurance captives, community health plans, and association health programs for small businesses; SMR, a program manager specializing in customized self-funded benefits plans for businesses; ICE is, an MGU, which specializes in underwriting and providing administrative functions on behalf of stop loss carriers; and enhance do it yourself benefit system (eDIYBS), a web-based SaaS quoting platform to qu... [Read more]
Financial Performance
In 2025, Health In Tech's revenue was $33.33 million, an increase of 70.99% compared to the previous year's $19.49 million. Earnings were $1.28 million, an increase of 90.74%.
Financial StatementsAnalyst Summary
According to 2 analysts, the average rating for HIT stock is "Buy." The 12-month stock price target is $2.37, which is an increase of 522.73% from the latest price.
News
Health In Tech Appoints Tim Cortes as Independent Director, Chair of the Compensation Committee
Technology veteran brings more than 30 years of experience in technology innovation, clean energy, power systems, and product development to support Health In Tech's AI strategy and product innovation...
Health In Tech Appoints Wall Street Research and Capital Markets Veteran Christina R. Valauri to Board of Directors
Seasoned public company director and senior capital markets executive brings more than 30 years of financial services leadership, corporate governance and strategic advisory experience, includes senio...
Health In Tech price target lowered to $2 from $4 at Craig-Hallum
Craig-Hallum lowered the firmās price target on Health In Tech (HIT) to $2 from $4 and keeps a Buy rating on the shares. The firm views 2026 as a yearā¦
Health In Tech price target lowered to $2 from $4 at Craig-Hallum
Craig-Hallum lowered the firmās price target on Health In Tech (HIT) to $2 from $4 and keeps a Buy rating on the shares. The firm views 2026 as a yearā¦
Health In Tech price target lowered to $1 from $1.25 at Maxim
Maxim analyst Allen Klee lowered the firmās price target on Health In Tech (HIT) to $1 from $1.25 and keeps a Buy rating on the shares. The firm cites theā¦
Health In Tech Earnings Call Transcript: Q3 2026
Q3 revenue and profitability declined amid carrier-transition timing, lower ICE fees, and a one-time credit provision, while SMR fees held steady and cash use improved sequentially. The focus is converting pipeline and launching new products, with 2027 guidance still under review.
Health In Tech Earnings release: Q3 2026
Health In Tech released its Q3 2026 earnings on November 12, 2026, summarizing the period's financial results.
Health In Tech Slides: Q3 2026
Health In Tech has posted slides in relation to its Q3 2026 quarterly earnings report, which was published on November 12, 2026.
Health In Tech Quarterly report: Q3 2026
Health In Tech has published its Q3 2026 quarterly earnings report on November 12, 2026.
Health In Tech reports Q3 EPS (11c) vs. 1c last year
Reports Q3 revenue $6.6M vs. $8.49M last year. CEO Sanjay Shrestha commented: āHealth In Tech (HIT) has established a strong technology foundation and a substantial pipeline of commercial opportunitie...
Health In Tech cuts 2026 revenue view to $30M from $45M-$50M, consensus $31.79M
The revision primarily reflects the delayed commencement of certain new policies resulting from the transition to a new carrier, which temporarily extended underwriting and onboarding timelines. These...
Health In Tech Reports Third Quarter 2026 Financial Results
Contracted Revenue of $32.7 Million for the First Nine Months of 2026 Pipeline Revenue of $156.4 Million as of October 30, 2026 Distribution Partners Grew 15.9% Year Over Year STUART, Fla., Nov. 12, 2...
Health In Tech Transcript: AGM 2026
All five director nominees were elected, and stockholders approved the authorized-share increase, SEPA issuance, amended 2024 Plan, and auditor ratification. Shares representing 90.53% of outstanding voting power were represented.
Health In Tech to Announce Third Quarter 2026 Financial Results on November 12, 2026
STUART, Fla., Oct. 29, 2026 /PRNewswire/ -- Health In Tech, Inc. (Nasdaq: HIT), an AI-enabled InsurTech platform company, today announced that it will release financial results for the third quarter e...
Health In Tech Proxy statement: Proxy filing
Health In Tech filed a proxy statement on October 28, 2026, providing details for shareholder voting and corporate governance matters.
Health In Tech CEO Tim Johnson to switch to chairman, Sanjay Shrestha to succeed
Health In Tech (HIT) announced the appointment of Sanjay Shrestha as CEO, effective October 20. Shrestha will succeed founder Tim Johnson, who will transition to executive chairman of the boardā¦
Health In Tech Appoints Sanjay Shrestha as Chief Executive Officer to Lead Next Phase of Growth and Strategic Expansion
Founder Tim Johnson to become Executive Chairman, continuing to drive long-term strategy, technology innovation and product development Leadership evolution designed to accelerate commercial execution...
Health In Tech to Host Annual Meeting of Stockholders
STUART, Fla., Oct. 16, 2026 /PRNewswire/ -- Health In Tech, Inc. (Nasdaq: HIT) ("Health In Tech" or the "Company") will host its 2026 Annual Meeting of Stockholders (the "2026 Annual Meeting") on Tues...
Health In Tech Registration statement: Registration filing
Health In Tech filed a registration statement on October 13, 2026, providing details about a securities offering with the SEC.
Health In Tech Proxy statement: Proxy filing
Health In Tech filed a proxy statement on October 13, 2026, providing details for shareholder voting and corporate governance matters.
Health In Tech Launches HitRix, a Broker-First Environment for Self-Funded Stop-Loss Placement
STUART, Fla., Oct. 8, 2026 /PRNewswire/ -- Health In Tech, Inc. (Nasdaq: HIT) ("Health In Tech" or the "Company"), an AI-enabled InsurTech platform company, today announced the next release of HitRix,...
Health In Tech to Attend the 17th Annual Craig-Hallum Alpha Select Conference
STUART, Fla., Oct. 2, 2026 /PRNewswire/ -- Health In Tech, Inc. (Nasdaq: HIT), an AI-enabled InsurTech platform company ("Health In Tech" or the "Company"), today announced that representatives from t...
Health In Tech Proxy statement: Proxy filing
Health In Tech filed a proxy statement on October 1, 2026, providing details for shareholder voting and corporate governance matters.
Health In Tech jumps after launching new AI-powered platform
Shares of Health In Tech (HIT) are moving higher after the company announced the launch of HitRix, a new AI-powered platform ādesigned to simplify one of the most complex andā¦
Health In Tech sees 2026 revenue $33M, consensus $41.19M
Health In Tech (HIT) said when announcing the launch of HitRix, its new AI-powered platform, āThe Company also updated its full-year 2026 revenue outlook to approximately $33 million, roughly inā¦